DiscoverBig Picture Medicine#126 Drug Discovery is Becoming More $$$ — Here's Why, And The Startup Fixing It (Lindus Health)
#126 Drug Discovery is Becoming More $$$ — Here's Why, And The Startup Fixing It (Lindus Health)

#126 Drug Discovery is Becoming More $$$ — Here's Why, And The Startup Fixing It (Lindus Health)

Update: 2023-10-31
Share

Description

Drug discovery is becoming more expensive and producing less results than ever before (Eroom's Law)—why?

One of the ballooning costs are clinical trials. Pharma/biotech often outsource their trials to CROs (contract research organisations).

But many CROs are incentivised to make trials as bloated and inefficient as possible. That means more money and less results.

Meri Beckwith is building the anti-CRO: Lindus Health—to solve this problem.




0:00 Intro


1:39 The big problem in drug discovery


4:10 Why do CROs exist?


7:24 The incentive problem in drug discovery/CROs


10:57 Pharma are anti-startups


12:11 How much a clinical trial costs


15:11 How can you compete with big CROs?


17:26 Are you going to build your own drug pipeline?


18:56 Lessons from VC to Founder


23:42 Brand/PR/Positioning as a biotech startup


29:03 Billion dollar ideas in bio/health


31:33 Habits that have helped Meri


Links


Lindus Health: https://www.lindushealth.com/


Meri Beckwith: https://twitter.com/meribeckwith


Mithi Thaya: https://www.linkedin.com/in/mithi-thaya/


Dr Mustafa Sultan: https://www.musty.io/

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

#126 Drug Discovery is Becoming More $$$ — Here's Why, And The Startup Fixing It (Lindus Health)

#126 Drug Discovery is Becoming More $$$ — Here's Why, And The Startup Fixing It (Lindus Health)

Mustafa Sultan, MD